Children with partial IgA deficiency: clinical characteristics observed in the pediatric rheumatology clinic

Aarti Shakkottai1, Krishnaveni Bupathi, Ankit P Patel

  • 1University of Michigan, Ann Arbor, MI, USA.

Clinical Pediatrics
|August 27, 2011
PubMed

Insights

Partial immunoglobulin A (IgA) deficiency is linked to rheumatic conditions. This study found many patients with partial IgA deficiency experienced joint pain, swelling, and stiffness, suggesting a connection.

Area of Science:

  • Immunology
  • Rheumatology
  • Pediatrics

Background:

  • Limited literature exists on partial immunoglobulin A (IgA) deficiency.
  • Understanding the clinical spectrum of partial IgA deficiency is crucial.

Purpose of the Study:

  • To describe the clinical manifestations in patients with partial IgA deficiency.
  • To explore associations between partial IgA deficiency and rheumatic symptoms.

Main Methods:

  • Retrospective chart review of 13 pediatric patients with partial IgA deficiency.
  • Assessment of symptoms including rashes, joint pain, joint swelling, and morning stiffness.
  • Evaluation for frequent infections, allergies, and elevated antinuclear antibody (ANA).

Main Results:

  • Eleven of 13 patients reported joint pain, swelling, or morning stiffness.
  • Six patients had a diagnosis of a defined rheumatic disease.
  • Four patients experienced frequent infections; two reported allergies.

Conclusions:

  • Partial IgA deficiency may be associated with rheumatic diseases.
  • Symptoms like joint pain, swelling, and stiffness are common in patients with partial IgA deficiency.
  • Further research with larger cohorts is necessary to validate these findings.

Related Concept Videos

Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...